help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on October 16, 2003
Endocrinology, doi:10.1210/en.2003-0772
A more recent version of this article appeared on February 1, 2004
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
145/2/613    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, J.
Right arrow Articles by Freeman, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, J.
Right arrow Articles by Freeman, M. R.

Submitted on June 20, 2003
Accepted on October 10, 2003

Involvement of Cholesterol-rich Lipid Rafts in Interleukin-6-induced Neuroendocrine Differentiation of LNCaP Prostate Cancer Cells

Jayoung Kim1, Rosalyn M. Adam1, Keith R. Solomon1, and Michael R. Freeman1*

1 The Urologic Laboratory, Department of Urology, Department of Orthopaedic Surgery, Children's Hospital Boston; and the Department of Surgery, Harvard Medical School, Boston, MA

* To whom correspondence should be addressed. E-mail: michael.freeman{at}tch.harvard.edu.

IL-6 is an inflammatory cytokine that has been linked to aggressive prostate cancer (PCa). Previous studies have demonstrated that IL-6 can enhance the differentiation of PCa cells toward a neuroendocrine (NE) phenotype, a possible indicator of hormone-refractory disease. In this report, we present evidence that the mechanism of IL-6-stimulated NE differentiation employs a detergent-resistant (lipid raft) membrane compartment for signal transduction in LNCaP PCa cells. STAT3, a mediator of IL-6 signaling, was rapidly phosphorylated and translocated to the nucleus in LNCaP cells treated with IL-6. Both processes were inhibited by filipin, a cholesterol-binding compound that disrupts plasma membrane lipid rafts. Isolation of Triton X-100-insoluble raft fractions from LNCaP cells by discontinuous sucrose gradient centrifugation demonstrated that the 80 kDa IL-6 receptor localized almost exclusively to the raft compartment. Although STAT3 was located predominantly in the Triton X-100-soluble subcellular fraction in exponentially growing cells, abundant phosphorylated STAT3 was detected in the raft fraction following stimulation with IL-6. Increases in expression of the NE marker, neuron-specific enolase (NSE), and NSE promoter activity following IL-6 treatment were reduced after membrane rafts were disrupted by filipin treatment. LNCaP cells expressed the raft-resident proteins flotillin-2 and Gi{alpha}2, but notably not caveolins, the predominant structural protein present in caveolar membrane rafts in many tissues and tumor cells. These results are the first to define a role for lipid raft membrane microdomains in signal transduction mechanisms capable of promoting the NE phenotype in PCa cells and they demonstrate that the raft compartment is capable of mediating such signals in the absence of caveolins. Our results also suggest a mechanistic role for membrane cholesterol in cell signaling events relevant to PCa progression.


Key words: cholesterol • STAT3 • caveolin • detergent-resistant microdomains (DRMs)




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
D. E. Frigo and D. P. McDonnell
Differential effects of prostate cancer therapeutics on neuroendocrine transdifferentiation
Mol. Cancer Ther., March 1, 2008; 7(3): 659 - 669.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
T.-C. Yuan, S. Veeramani, and M.-F. Lin
Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells
Endocr. Relat. Cancer, September 1, 2007; 14(3): 531 - 547.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Kim, R. M. Adam, and M. R. Freeman
Trafficking of Nuclear Heparin-Binding Epidermal Growth Factor-like Growth Factor into an Epidermal Growth Factor Receptor-Dependent Autocrine Loop in Response to Oxidative Stress
Cancer Res., September 15, 2005; 65(18): 8242 - 8249.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. G. Coles, C. Boscarino, M. Takahashi, D. Grant, A. Chang, J. Ritter, X. Dai, C. Du, G. Musso, H. Yamabi, et al.
Cardioprotective stress response in the human fetal heart
J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1128 - 1136.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. J. George, S. Halabi, T. F. Shepard, B. Sanford, N. J. Vogelzang, E. J. Small, and P. W. Kantoff
The Prognostic Significance of Plasma Interleukin-6 Levels in Patients with Metastatic Hormone-Refractory Prostate Cancer: Results from Cancer and Leukemia Group B 9480
Clin. Cancer Res., March 1, 2005; 11(5): 1815 - 1820.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society